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Abstract
Unfortunately, the United States has experienced approximately 575,000 deaths as a
direct result of COVID-19, with elderly, Hispanic, and Black Americans experiencing the
greatest risk (CDC, 2020). Although most individuals recover from mild to moderate
COVID-19 infections within a few weeks, some may experience lingering symptoms for
many months (Mayo Clinic, 2020). These individuals are commonly known as COVID19 long-haulers. In order to properly assist in the well-being of COVID-19 long-haulers,
more needs to be understood in terms of how gender, race, stress, and social support
impact symptomatology within this population. The present study seeks to address this
gap in the literature by examining the frequency and severity of symptoms experienced
by COVID-19 long-haulers throughout their illness. Independent t-tests were used to
assess the differences in symptoms between females and males, and also White and
BIPOC participants. Regression analyses were conducted to determine the prediction of
COVID-19 symptom frequency and severity by stress, social support, gender, and race.
Results indicate that both social support and stress predict COVID-19 severity and
frequency in several symptom domains. In addition, being female predicts COVID-19
symptom severity and frequency in the pain and neurocognitive domains. The
implications of this study’s findings include helping COVID-19 long-haulers in
managing their stress, potentially through increasing social support. This is especially
important for female long-haulers.

Keywords: COVID-19, long-haulers, gender, race, stress, social support
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Examining COVID-19 Long-Haulers Along Gender, Race, Stress, and Social
Support Variables
Introduction
In November 2019, the world changed as a result of the global pandemic caused
by the severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) and the resulting
coronavirus disease (COVID-19). In all areas of the globe, communities have struggled to
keep up with the demands placed on health care systems, businesses, and daily life. In the
United States, nearly a quarter of middle-income and half of lower-income individuals
lost their jobs or took pay cuts in April 2020 (Parker et al., 2020). A majority of families
have needed to make adjustments as their children stayed home and engaged in some
form of distance learning (McElrath, 2020). And as individuals faced increased stress and
decreased social support as a result of the pandemic, increases in mental health and
substance use concerns have occurred (Czeisler et al., 2020). It is clear that the COVID19 pandemic has impacted at least some aspect of life for everyone and has been a true
global crisis.
Although the pandemic has indeed impacted everyone, it has not had equal effects
on each individual. One group that is experiencing a unique set of challenges on top of
the “average” pandemic stressors is COVID-19 long-haulers, a group of individuals who
do not recover from the COVID-19 disease within a two-week period and experience
lingering symptoms for many months (Mayo Clinic, 2020). This group is particularly
susceptible to increases in stress and decreases in social support, as they often experience
severe symptoms that can cause an inability to maintain full-time jobs (Mohan, 2020) and
maintain close relationships as a result of quarantining during the course of the illness.
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While it is clear that this group faces increased levels of stress and decreased levels of
social support after contracting the virus, it is not clear whether those experiences may
also increase the likelihood of experiencing long-term symptoms common to the COVID19 long-hauler population. In addition, demographic characteristics, such as gender and
race, may increase the probability of experiencing long-term effects as a result of
COVID-19.
COVID-19
COVID-19 is a type of coronavirus (Sauer, 2020) that is primarily spread through
person-to-person contact (Centers for Disease Control and Prevention [CDC], 2020;
World Health Organization [WHO], 2020). Although older individuals and those with
underlying medical conditions are more at risk for developing severe complications, such
as needing ventilator support (CDC, 2020; WHO, 2020), the virus has negatively and
severely impacted people of all ages and backgrounds. Symptoms of the disease vary,
ranging from the more common fever, dry cough, and fatigue to the less common sore
throat, rash, and loss of taste and smell (WHO, 2020). Unfortunately, the United States
has experienced approximately 575,000 deaths as a direct result of COVID-19, with
Hispanic and Black Americans experiencing the greatest vulnerability to infection and
death (Rossen et al., 2020). This stress associated with losing a family member––a key
source of social support––greatly impacts the well-being of the surviving family and
community members, who themselves may be battling the virus.
COVID-19 Long-Haulers. The experience of an infection with COVID-19 is
different for each person and the course of illness is largely unpredictable. Individuals
usually recover from mild to moderate COVID-19 infections (i.e., not needing to be

4
hospitalized or intubated) within a few weeks, however some individuals may experience
lingering symptoms for many months (Mayo Clinic, 2020). Like the symptoms of the
virus itself, these persisting symptoms are multi-system. These symptoms can include
fatigue, joint pain, loss of hair, blood clots, and challenges associated with memory and
concentration (Mayo Clinic, 2020). Individuals who are experiencing this “long COVID”
have either not fully recovered from their initial infection or have recovered but still
experience symptoms intermittently (Mahase, 2020). These individuals often self-identify
as COVID-19 long-haulers and have come together as a group to draw attention to their
unique plight.
Chronic Illness
It is becoming clear that the experiences and recoveries of COVID-19 longhaulers are similar to those who have suffered long-term effects as a result of other viral
infections, such as the Spanish flu (Radusin, 2012), Ebola (Wilson et al., 2019), and the
Epstein-Barr virus (Buchwald et al., 2000). Most notably, a commonality between
COVID-19 long-haulers and other post-viral groups is persistent fatigue after minimal
physical or mental effort, often known as post-exertional malaise (PEM; CDC, 2019).
Also similar to COVID-19 long-haulers, individuals with various chronic illnesses have
shown varying levels of adaptation to their illness as a result of perceived stress and
social support available to the individual affected with the illness (Acciari, 2019; Doeglas
et al., 1994; Griffin et al., 2001). Stress and social support affect both psychological
adjustment to the illness as well as physiological outcomes. In addition, factors that may
affect an individual’s level of stress and social support are the person’s gender and race
(Curtis et al., 2010; Duru, 2012). Overall, understanding which factors are influential to
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health outcomes for COVID-19 long-haulers is critical to supporting this group and those
most vulnerable within the group.
Stress. As a result of this current pandemic, understanding the effects of stress is
essential to assisting individuals, especially those directly affected by the COVID-19
illness. It goes without saying that the COVID-19 pandemic has been a source of added
stress for a majority of people the world over. Sources of stress include loss of work,
threat of loss of housing, fear of contracting the virus through work, and changes in daily
routines. It is necessary to acknowledge that different populations have not been affected
equally by the COVID-19 pandemic. Many vulnerable groups, such as people who are
low-income, experienced an already elevated level of stress prior to the pandemic and
have been most susceptible to increased insecurity and stress during this time (Karpman
et al., 2020).
Stress has often been connected to the development of chronic illness and how
one is able to cope with the illness. Serious, prolonged stress, such as that related to posttraumatic stress disorder (PTSD), has been linked to an increased risk of developing
chronic illness (Nobles, 2015). In addition, for people with myalgic
encephalomyelitis/chronic fatigue syndrome (ME/CFS), stress has been found to be a
significant contributor to the illness onset and progression, affecting especially
psychological functioning and levels of fatigue (Devendorf et al., 2016; Hatcher et al.,
2003; Salit, 1997). The experience of stress has also been connected to the development
of other illnesses, such as HIV/AIDS, upper respiratory tract infections, and autoimmune
diseases (Cohen et al., 2007). In essence, stress is a critical factor for the susceptibility to
and the progression of chronic illness. Although physical symptoms may fluctuate or
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even improve over time for people experiencing chronic illness, functionality related to
psychological and other neurocognitive symptoms has been shown to worsen in people
experiencing elevated amounts of stress (Devendorf et al., 2016). As a result, when
considering vulnerability to the COVID-19 disease, stress may be a significant factor in
susceptibility to the illness, the length of recovery time, and an indicator for prolonged
psychological impacts.
Social Support. In addition to the added stress caused by the loss of job security,
normalcy in daily life, and that generally brought upon by this pandemic, understanding
how the loss of social support has impacted quality of life is also essential. Like levels of
stress, social support access varies based on several factors, such as the ability to access
technology and form a “bubble” of family or friends who have been able to successfully
quarantine for the recommended two-week time period. Generally, however, the loss of
social support has come in the form of government-mandated lockdowns and quarantines
(Wu et al., 2020) intended to drastically isolate individuals from everyday interactions
that would otherwise organically occur outside of the household. Some specific examples
of this have taken the form of working from home, canceling large family gatherings, and
limiting everyday trips to local businesses. These seemingly small and insignificant social
interactions, once taken for granted by many, traditionally add up to form networks of
support. Now, as the pandemic continues to rage on, the number of daily interactions in
all forms, inconsequential or deeply meaningful, have been severely limited. As a result,
people are left to handle the stress of the pandemic with far less social support.
Social support is a crucial factor in chronic illness outcomes. Individuals who
receive adequate levels of support in dealing with their illness are better able to cope and
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manage their illness (Gallant, 2003). One reason this may be is that social support is
critical to handling stress that may arise from not being believed or the potential stigma
related to chronic illness. Individuals with less social support anticipate experiencing
greater stigma from family, friends, colleagues, and medical providers, which then
increases stress and lowers quality of life (Earnshaw et al., 2011). In addition, social
support may impact actual health outcomes related to chronic illness. Social support has
been shown to decrease levels of fatigue by those experiencing chronic illness (Jason et
al., 2010). This is significant, as one of the major symptoms reported by COVID-19 longhaulers is fatigue (Mayo Clinic, 2020), which can greatly interfere with the ability to
accomplish basic, everyday tasks. As a result, increasing ways to access and maintain
social support during the pandemic can have very real effects on one of the major
symptoms lowering the quality of life of COVID-19 long-haulers.
Gender. Women have dealt with an increase in burden as a result of the COVID19 pandemic. Millions of women considered leaving work to provide childcare (Kashen
et al., 2020; Masterson, 2020) and approximately one in three jobs held by women have
been labeled “essential” (e.g., hospitality, retail, and health care), which increases the risk
of exposure to COVID-19 (Robertson & Gebeloff, 2020). Although COVID-19 has
caused the death of more men than women, in the United States, women are more likely
to contract the virus (CDC, 2020). Based on previous knowledge of post-viral long-term
effects, such as those related to ME/CFS (CDC, 2018), women may be more likely to
experience long-lasting effects of COVID-19. Although women are less likely to develop
severe complications or die as a result of the disease, women are being exposed at higher
rates. As a result, women are more likely to contract COVID-19 and have been more
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likely to self-identify as being COVID-19 long-haulers (O’Rourke, 2021; Rubin, 2020;
Velasquez-Manoff, 2021).
Along with logistical reasons, such as exposure rates, women may be more
susceptible to long-term effects of different illnesses as a result of stress and social
support levels. It has been found that women who perceive greater stress and lesser social
support have a more difficult time adjusting to their chronic illness (Curtis et al., 2010).
The loss of social support is significant because it is connected to several health factors,
including reactivity to stress, perceived lower quality of life, and a decreased ability to
cope with pain related to illness (Zautra et al., 1999). For women in particular, social
support is essential to quality of life, as many women rely on their friends and extended
family for support in dealing with stressful situations (Hintikka et al., 2000). For women
with chronic illness, it has been demonstrated that the loss of this support can have a
direct effect on physical and psychological difficulties associated with their illness
(Hintikka et al., 2000; Zautra et al., 1999), which is necessary for understanding the
vulnerability women may have to becoming COVID-19 long-haulers.
One group that is clearly experiencing an increase in stress during the COVID-19
pandemic is medical providers. It is difficult to imagine the level of stress felt by medical
providers at this time, especially when considering that many choose to isolate away from
family in order to prevent transmission of the virus (Weise, 2020). Specifically, nurses,
an occupation overwhelmingly composed of women (Schnur, 2020), may be at a unique
risk of becoming COVID-19 long-haulers. Because of their occupation, they may be
exposed to the virus on a daily basis. In addition, the stress associated with the threat of
contracting COVID-19, along with the stress of working in an environment that may not
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be safe (due to lack of personal protective equipment, for example), may be associated
with illness-related symptoms reported by women experiencing the hallmark symptom of
fatigue (Wagner & Jason, 1997).
Race. Although the virus is most detrimental in terms of death to the elderly
population and those who have prior comorbidities (CDC, 2020), there have been
concerning data showing that Black, Indigenous, and People of Color (BIPOC) have also
faced disproportionate rates of death (Golestaneh et al., 2020; Ledur, 2020). Due to
several factors ranging from living situations and type of work to a lack of strong
community health systems, BIPOC have been more likely to contract COVID-19 and,
unfortunately, die from the illness (Marshall, 2020). For BIPOC communities, which
have historically faced structural oppression that has resulted in continual discrimination
and economic disadvantage, COVID-19 has been devastating and requires immediate
amelioration. This is especially vital for limiting the rate of individuals who become
COVID-19 long-haulers among this population. In addition, understanding how COVID19 impacts this population specifically is crucial for providing long-term resources,
especially once the pandemic begins to recede.
In addition to the discrimination felt broadly in society, discrimination from the
health care system specifically contributes to stress and decreased health outcomes.
Disparities in health outcomes among BIPOC are well-documented (Copeland, 2005),
with BIPOC experiencing higher rates of maternal death (Holdt Somer et al., 2017),
diabetes (Peek et al., 2007), and cancer (Singh & Jemal, 2017), compared to White
individuals. These disparities continue to occur during the current pandemic and have
directly affected outcomes related to COVID-19 infections in BIPOC in America. The
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allostatic load created by this chronic life stress experienced by BIPOC individuals,
especially Black Americans, has been connected to increased health disparities, including
increased mortality, compared to White Americans (Duru, 2012). Black individuals who
experience extreme long-lasting stress, such as that related to PTSD and social
inequalities, are more likely than White individuals to develop chronic illnesses such as
diabetes (Nobles et al., 2015). This is important given that BIPOC individuals may be at
an increased risk of developing COVID-19 as a result of this prolonged stress.
The stress endured by BIPOC communities is undeniably compounded at this
time. Dealing with inadequate or non-existent health care systems, the loss of family
members (key forms of social support), insecure employment, the threat of losing one’s
home, and many other stressors compound the stress already faced by BIPOC individuals
as a result of historical discrimination. Along with the COVID-19 pandemic, the BIPOC
community, especially Black Americans, has been dealing with another pandemic in the
form of racism and its various, negative outcomes (Laurencin, 2020). As a result of these
factors, the BIPOC community is uniquely susceptible to becoming COVID-19 longhaulers and may be more vulnerable to the long-term hardships associated with the
condition––physically, socially, and economically.
Theory: Psychosocial Theory
The connection between chronic stress, social support, and illness has been
established. In addition, previous research on chronic illness has revealed that women and
racial minorities are more at risk for developing a variety of illnesses, which may include
COVID-19, and having poorer long-term outcomes associated with these illnesses. One
theory developed to encompass this idea is the psychosocial theory. This theory explains
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that chronic social stressors alter susceptibility to illness and can bring about health
damaging behaviors, which can include those related to substance use and poor diet
(Krieger, 2012).
This framework provides an understanding for how the social environment and
demographic variables impact health outcomes. Psychosocial factors have been shown to
contribute to psychological well-being, whether or not a person has a chronic illness. But
for those who do have a chronic illness, these factors may be especially impactful. For
those who report strong social support in terms of having a partner and perceived support,
for example, feelings of depression are lowered for those living with a chronic illness
(Bisschop, 2004). This theory has also been used in several real-world settings, one of
which being the workplace. Psychosocial factors, such as work-related stress as a result
of conflicting demands and excessive workload, contribute to the onset of cardiovascular
disease through increasing blood pressure (Gilbert-Ouimet, 2014), which demonstrates
the link between one’s environment, stress level, and illness outcome.
When trying to understand the link between stress, social support, and chronic
illness, it is necessary to consider how stress and social support may impact various
phases of an illness. Psychosocial theory provides a framework for describing how these
factors can impact the onset, severity, and progression of a disease (Cohen, 1988). The
interaction of stress and social support is significant, as social support may provide a
buffer for stress, which may lessen the biological responses that can influence the course
of chronic illness (Cohen, 1988).
Because of the discrimination felt by women and BIPOC in American society
generally and the increased health risk of experiencing stress as a result of that
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discrimination, especially during the current pandemic, it can be predicted that women
and BIPOC are more susceptible to developing long-lasting symptoms of COVID-19. In
addition, as many have lost frequent and reliable social support, an increase in stress can
be expected, therefore having a negative impact on those experiencing lasting symptoms
of COVID-19.
Rationale
There is no previous research related to symptomatology that is analyzed with
consideration to gender, race, stress, and social support variables among people
experiencing COVID-19. Understanding how these factors influence the experience of
COVID-19 in the long-hauler population is essential to addressing the specific needs of
this group, which is a group that has been frequently overlooked during this time. In
order to properly assist in the well-being of COVID-19 long-haulers––a group that will
only continue to grow in number––more needs to be understood in terms of who is most
vulnerable to and how stress and social support may impact on-going symptomatology.
When this is done, finding effective ways to decrease stress and increase social support in
the most vulnerable can be achieved. This will become especially important as the
pandemic begins to abate and attention towards those afflicted with long-lasting COVID19 symptoms starts to dissipate.
The present study seeks to address this gap in the literature by examining the
frequency and severity of symptoms experienced by COVID-19 long-haulers, averaged
and grouped into domains. The primary symptoms considered will be those reported by
participants during the two most recent weeks of their illness. As these participants selfidentify as COVID-19 long-haulers, it is necessary to determine how their symptoms are
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affecting them after an extended period of time of being ill. In addition, these symptoms
will be examined along several key variables critical at this time: gender, race, stress, and
social support. When researchers understand how these variables relate to symptom
frequency and severity among COVID-19 long-haulers, local and federal governments
can direct more resources to those communities and populations most likely to experience
long-term impacts of the disease in order to equitably aid in prevention and recovery.
Hypotheses
Hypothesis I
There will be significant differences in COVID-19 symptomatology between
participants who identify as being female and participants who identify as male, with
participants identifying as female reporting more severe and more frequent COVID-19
symptoms.
Hypothesis II
There will be significant differences in COVID-19 symptomatology between
participants who identify as being White and participants who identify as being a racial or
ethnic minority, with participants identifying as a minority reporting more severe and
more frequent COVID-19 symptoms.
Hypothesis III
Elevated levels of stress and decreased levels of social support will account for a
statistically significant prediction of more frequent and more severe COVID-19
symptoms in nine symptom domains.
Hypothesis IV
Elevated levels of stress, decreased levels of social support, identifying as female,
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and identifying as an ethnic or racial minority will account for a statistically significant
prediction of more frequent and more severe COVID-19 symptoms in nine symptom
domains.
Method
Participants
Participants were recruited from an online sample, primarily through the use of
social media. The sample was diverse across age, gender, education, and income.
Participants were adults over the age of eighteen who self-identified as being a COVID19 long-hauler with symptoms lasting for longer than two weeks after initial infection.
After accounting for significant amounts of missing survey information, a final sample of
299 adults was examined.
Recruitment. The participants for this study were recruited on the basis of
experiencing COVID-19 symptoms for longer than the CDC’s standard two-week length
of illness. Participants were recruited using various online methods, including email and
postings on social media outlets, particularly those related to supporting COVID-19 longhaulers. Scripted messages directed participants to REDCap, a secure web application,
and all aspects of participation were completed online. Participants provided informed
consent and completed several questionnaires. Those who consented to completing the
questionnaires reflected on their symptomatology for two time periods: the first time
period being the first two weeks of illness with COVID-19 and then, second, within the
past week of illness. Participants reflected on the impacts the pandemic has had on their
lives in a separate questionnaire. Participants were not compensated for completing the
survey.
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Materials
DePaul Symptom Questionnaire (DSQ). Participants completed the DePaul
Symptom Questionnaire (Jason & Sunnquist, 2018), a 54-item self-report measure of
myalgic encephalomyelitis/chronic fatigue syndrome symptomatology. Participants rated
the symptoms in terms of frequency during the first two weeks of their illness on a 5point scale with 0 = “none of the time,” 1 = “a little of the time,” 2 = “about half the
time,” 3 = “most of the time,” and 4 = “all of the time.” In addition, participants were
asked to rate the severity of each symptom on a 5-point scale with 0 = “symptom not
present,” 1 = “mild,” 2 = “moderate,” 3 = “severe,” and 4 = “very severe.” The frequency
and severity score for each symptom were then multiplied by 25, creating 100-point
scales. The 100-point score for both frequency and severity were then averaged, creating
a final composite score for each symptom. Jason and Sunnquist (2018) reviewed research
on the DSQ and found excellent psychometric properties of both reliability and validity.
In addition, composite scores for various symptom domains were computed by
averaging all 100-point scores for the symptoms within each domain. These domains are
groupings of the symptoms, including immune system symptoms, neuroendocrine
symptoms, pain symptoms, gastro-intestinal symptoms, sleep symptoms, post-exertional
malaise symptoms, neurocognitive symptoms, and orthostatic symptoms (see Appendix
A for symptoms in each domain).
CDC symptoms. The CDC lists several additional symptoms of COVID-19 on
their website (CDC, 2020). These items include dry cough, loss of taste and smell,
difficulty breathing, diarrhea, nasal congestion, and loss of hair. As these items are not on
the original DSQ, they were added to the survey completed by the COVID-19 long-
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hauler sample and participants rated these symptoms on the basis of frequency and
severity during the first two weeks and past two weeks of illness. These symptoms were
transformed into composite scores in the same way as the original DSQ symptoms. This
grouping was its own, additional domain.
Coronavirus Impact Scale. Participants completed the Coronavirus Impact and
Pandemic Stress Scale (Stoddard & Kaufman, 2020). The Coronavirus Impact Scale is a
12-item questionnaire assessing various dimensions of daily life, including routines, food
access, medical/mental healthcare access, and employment. Respondents rated whether
and how much the COVID-19 pandemic has affected and changed daily life on a fourpoint scale with 0 = “no change,” 1 = “mild change,” 2 = “moderate change,” and 3 =
“severe change.”
This is a newly developed scale created to meet the unique and pressing concerns
of the current pandemic and has therefore not been tested extensively for its reliability
and validity. However, the authors found in the summer of 2020 that initial validation
performed on four samples suggests that items one through eight are well distributed with
acceptable distributions for psychometric analysis. The scale has continued to be widely
used during this time and has been registered as part of the NIH OBSSR suite of common
instruments (Stoddard & Kaufman, 2020). For this study, the scale in its entirety was not
used. Instead, the analyses focused on two survey items: “Access to extended family and
social support” and “Experience of stress related to the coronavirus pandemic.”
Procedure
Prior to completing the questionnaires, participants completed a consent form,
which detailed information about the survey, including the time to complete all parts
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(approximately 30 minutes) and who to contact with questions. After consenting,
participants then completed the demographics portion, which included questions specific
to COVID-19 (e.g., “When did you get sick with COVID-19”). Following the
demographics portion, participants completed the DSQ twice: first reflecting on
symptoms during the first two weeks of illness with COVID-19, then reflecting on
symptoms experienced within the last week of illness. After DSQ completion,
participants completed the Coronavirus Impact Scale. Participants finished the survey by
completing questions regarding fatigue and medical history.
Results
Participant Characteristics
Participants in this study were 299 adults primarily from the United States of
America (approximately 90%). Participants self-reported symptoms of COVID-19 lasting
for an extended period of time (average length since symptoms began and survey
completion being approximately five months [M = 21.3 weeks, SD = 8.1 weeks]).
Participants comprised a diverse sample of race, sex (reported as gender in this study),
and socioeconomic status. See Table 1 for demographic information1.
Demographic Groupings. For the gender variable, female and male were the two
categories considered in the analyses, as non-binary did not meet the standard n = 20
participants required for analysis. In a similar way, race was split into two categories,
White and BIPOC, in order to achieve a sufficiently sized group comparison to White.
Participants were grouped into White if they checked the White box on the survey and
only the White box (n = 248). Participants were placed into the BIPOC group if they
1

The survey allowed participants to select more than one racial category, creating a total number of
participants in the race section greater than that in the overall survey.
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checked one or more of the following: Hispanic/Latino, Multiracial/Other, Asian/Pacific
Islander, American Indian/Alaskan Native, and Black/African American. Participants
who checked White and any other racial category box were also placed in the BIPOC
group (n = 51).
Table 1. Demographic characteristics
Participants (N = 299)
Age

M (SD)
45.10 (20.69)
% (n)

Gender
Female
Male
Non-binary

81.6 (244)
15.7 (47)
1.7 (5)

Race
White
Hispanic/Latino
Multiracial/Other
Asian/Pacific Islander
American Indian/Alaskan Native
Black/African American

90.3 (270)
7.4 (22)
7.0 (21)
3.3 (10)
2.3 (7)
1.7 (5)

Highest degree or level of education
Graduate or professional degree
Standard college degree
Partial college or specialized training
High school or G.E.D.
Some or less than high school
Missing

38.8 (116)
30.4 (91)
11.7 (35)
4.0 (12)
1.0 (3)
14.0 (47)

Preliminary Analyses
All data were analyzed using SPSS version 23.0 (IBM Corp., 2015).
Missing Data. Five hundred and ninety-six participants began the online survey
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but a large portion (approximately 49.8%) of these responses contained significant
amounts of missing data. Participants with missing data were excluded on the basis of not
completing ten percent or more of the DSQ symptomatology questions. The surveys of
the remaining 299 participants were examined for response compliance and outliers,
which were found to meet qualifications.
Assumptions. Normality was assessed by examining the dependent variables,
which in this study were the DSQ symptom domains at time one and time two. Each of
the nine domains at each time point were assessed on its mean, standard deviation,
skewness, and kurtosis. The analyses revealed that skew was the most pressing concern
with the data. One domain was shown to have a significantly high skew greater than 1.0:
immune domain at time point two (Skew[1.25]). To increase interpretability with
comparison to the other domains, the immune domain at time two was not transformed
for analyses and considered a limitation of the study.
Hypothesis I
An independent-samples t-test was conducted to determine if there were
significant differences between COVID-19 symptomatology reported by females and
males at each time point. A t-test was completed for the mean composite scores for each
of the nine symptom domains. To account for multiple t-tests being conducted with this
sample and to reduce the probability of Type I error, the p-value was set at the .01 alphalevel, instead of the traditional .05 level (Mudge et al., 2012).
During the first two weeks of illness, participants identifying as female reported
significantly higher symptom frequency and severity in several, but not all, domains
(Table 2). Females reported higher severity and frequency of symptoms in the PEM
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domain (M = 68.5, SD = 28.9) as compared to males (M = 56.2, SD = 32.1), t(290) =
2.63, p < .01. For the immune domain, females (M = 44.1, SD = 23.0) reported higher
symptom severity and frequency as compared to males (M = 32.0, SD = 23.0), t(290) =
3.28, p < .001. In the neuroendocrine symptom domain, females (M = 39.2, SD = 23.8)
again reported higher symptoms frequency and severity as compared to men (M = 26.8,
SD = 25.2), t(290) = 3.35, p < .001. For the orthostatic domain, females (M = 49.0, SD =
25.1) reported higher symptom severity and frequency as compared to males (M = 36.6,
SD = 28.0), t(290) = 3.05, p < .01. Finally, for the CDC domain, females (M = 38.7, SD =
19.2) reported higher symptom severity and frequency as compared to males (M = 29.1,
SD = 17.5), t(290) = 3.15, p < .01.
Table 2. Independent t-test for each symptom domain for females and males at time one.
Female
M
SD
Sleep
PEM
Neurocog
Immune
Neuroend
Pain
Gastro
Ortho
CDC

56.7
68.5
48.5
44.1
39.2
52.4
34.9
49.0
38.7

24.8
28.9
30.6
23.0
23.8
31.8
29.4
25.1
19.2

Male
M
SD
46.9
56.2
39.5
32.0
26.8
47.5
24.4
36.6
29.1

24.3
32.1
34.1
23.0
25.2
31.0
27.0
28.0
17.5

t-score
2.51
2.63*
1.81
3.28**
3.35**
0.98
2.29
3.05*
3.15*

*p < .01. **p < .001.
The second set of t-tests were conducted for the domains at the second time point,
which was the participants past two weeks of illness. At this time point, participants
identifying as female reported significantly higher symptom frequency and severity in
seven out of the nine domains, as compared to males (Table 3). Females reported higher
severity and frequency of symptoms in the PEM domain (M = 61.7, SD = 24.7), as
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compared to males (M = 45.3, SD = 32.3), t(290) = 3.94, p = .000. Similarly, females (M
= 52.1, SD = 26.9) reported higher severity and frequency of symptoms in the
neurocognitive domain, as compared to males (M = 36.0, SD = 29.0), t(290) = 3.72, p =
.000. In addition, females (M = 23.7, SD = 20.3) reported higher symptom severity and
frequency in the neuroendocrine domain, as compared to males (M = 15.1, SD = 21.0),
t(290) = 2.65, p < .01. For the pain domain, females (M = 47.7, SD = 30.1) reported
higher symptom severity and frequency, as compared to males (M = 32.8, SD = 32.4),
t(290) = 3.05, p < .01. Females (M = 29.8, SD = 25.8) also reported higher severity and
frequency of symptoms for the gastro-intestinal domain, as compared to males (M = 16.5,
SD = 21.5), t(290) = 3.31, p < .001. For the orthostatic domain, females (M = 37.4, SD =
21.5) again reported higher symptom severity and frequency, as compared to males (M =
27.7, SD = 22.4), t(290) = 2.79, p < .01. Finally, for the CDC domain, females (M = 25.5,
SD = 17.9) reported significantly higher symptom severity and frequency, as compared to
males (M = 17.3, SD = 15.8), t(290) = 2.94, p < .01.
Table 3. Independent t-test for each symptom domain for females and males at time two.
Female
M
SD
Sleep
PEM
Neurocog
Immune
Neuroend
Pain
Gastro
Ortho
CDC

48.4
61.7
52.1
19.5
23.7
47.7
29.8
37.4
25.5

23.5
24.7
26.9
18.1
20.3
30.1
25.8
21.5
17.9

*p < .01. **p < .001. ***p = .000.

Male
M
SD
40.9
45.3
36.0
13.3
15.1
32.8
16.5
27.7
17.3

24.9
32.3
29.0
16.5
21.0
32.4
21.5
22.4
15.8

t-score
1.99
3.94***
3.72***
2.22
2.65*
3.05*
3.31**
2.79*
2.94*
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Hypothesis II
After the two race groups (White and BIPOC) were established, independentsamples t-tests were conducted to determine if there were significant differences between
COVID-19 symptomatology reported by White and BIPOC participants at each time
point. A t-test was completed for the mean composite scores for each of the nine
symptom domains. The independent-samples t-tests found that, for race, participants
identifying as White and BIPOC did not differ significantly in any of the nine symptom
domains at time one (first two weeks of illness; Table 4). In addition, the independentsamples t-tests found that participants identifying as White and BIPOC did not differ
significantly in any of the nine symptom domains at time two (last two weeks of illness;
Table 5).
Table 4. Independent t-test for each symptom domain for White and BIPOC at time one.
White
M
SD
Sleep
PEM
Neurocog
Immune
Neuroend
Pain
Gastro
Ortho
CDC

54.8
66.9
45.6
42.2
37.1
50.9
33.5
47.3
36.9

25.2
29.7
31.0
22.2
25.1
31.1
28.3
25.4
18.3

BIPOC
M
SD
56.9
64.3
51.3
43.2
37.1
54.9
32.3
47.2
38.6

24.5
30.2
33.1
28.3
25.1
32.7
31.8
28.7
22.5

t-score
-0.53
0.56
-1.18
-0.29
0.00
-0.83
0.28
0.02
-0.56

*p < .01.
Table 5. Independent t-test for each symptom domain for White and BIPOC at time two.
White
M
SD
Sleep
PEM

47.1
59.5

23.4
26.6

BIPOC
M
SD
49.7
58.0

27.1
27.7

t-score
-0.69
0.37
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Neurocog
Immune
Neuroend
Pain
Gastro
Ortho
CDC

49.1
18.4
22.5
45.9
27.4
35.7
24.5

27.6
17.3
20.2
30.0
45.5
21.4
17.3

52.4
21.2
22.7
42.3
29.7
39.0
22.2

29.1
22.0
22.5
33.7
25.7
25.3
19.7

-0.79
-1.00
-0.07
0.77
-0.59
-0.95
0.85

*p < .01.
Hypothesis III
A Pearson product-moment correlation coefficient was conducted to measure the
strength of the relationship between stress and social support to discover whether these
two variables violated the assumption of multicollinearity. Stress and social support were
found to be moderately positively correlated, r(293) = .31, p = .000. This indicates that
these variables violate the assumption. Therefore, separate multiple regression analyses
were conducted for stress and social support.
Hypothesis IV
To assess the proportion of variance that is accounted for by stress, social support,
gender, and race, multiple linear regression analysis was used. This model allowed for the
variance of each variable to be accounted for while keeping the other variables constant.
The variables were entered into the model using forced entry of the three primary
variables for each set of regression analyses (stress, gender, and race; social support,
gender, and race), along with reported symptom domain scores at time one. A fifth
variable was entered into each model to account for the time a participant reported first
becoming sick with COVID-19 to the time they took the survey. A multiple linear
regression analysis was run for each of the symptom domains using this method.
To assess the proportion of variance that is accounted for by stress, gender, and
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race on participants symptom domain scores during the last two weeks of illness, these
variables were entered into a multiple regression analysis model. Time one domain scores
were also entered into the model as a predictor. In addition, to account for participant
duration of illness, this variable was entered into the model as well.
A multiple regression analysis was run to determine how time one sleep domain
scores, duration of illness, gender, race, and stress predicted symptom scores for the sleep
domain at time two (Table 6). Multiple R2 = 0.33, F(5, 280) = 29.27, p = .000. This
model demonstrated prediction of time two symptom scores for the sleep domain from
time one scores and stress scores, with an increase in time two sleep domain scores
connected to an increase in time one sleep domain score and stress scores. When time one
sleep domain score is held constant, time two score b = 0.45 and p = .000. When stress is
held constant, time two sleep domain score b = 6.80 and p = .000. This indicates that time
one sleep domain scores and stress scores account for a significant prediction of time two
sleep domain scores, whereas duration of illness, gender, and race do not.
Table 6. Regression analysis summary for stress predicting sleep domain score at time
two.
Predictors

B

(Constant)
T1Sleep
Duration
Female
BIPOC
Stress

11.76
0.45
-0.04
-1.75
1.72
6.80

95% CI

β

[1.44, 22.08]
[.35, .55]
0.46
[-.33, .24]
-0.01
[-7.74, 4.24] -0.03
[-4.31, 7.76] 0.03
[4.15, 9.45]
0.26

t
2.24
9.11
-0.30
-0.58
0.56
5.05

p
.026
.000
.768
.566
.575
.000

A multiple regression analysis was run to determine how time one PEM domain
scores, duration of illness, gender, race, and stress predicted symptom scores for the PEM
domain at time two (Table 7). Multiple R2 = 0.25, F(5, 280) = 20.20, p = .000. This
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model demonstrated prediction of time two symptom scores for the PEM domain from
time one scores and stress scores, with an increase in time two PEM domain scores
connected to an increase in time one PEM domain score and stress scores. When time one
PEM domain score is held constant, time two score b = 0.38 and p = .000. When stress is
held constant, time two PEM domain score b = 5.20 and p < .001. This indicates that time
one PEM domain scores and stress scores account for a significant prediction of time two
PEM domain scores, whereas duration of illness, gender, and race do not.
Table 7. Regression analysis summary for stress predicting PEM domain score at time
two.
Predictors

B

(Constant)
T1PEM
Duration
Female
BIPOC
Stress

18.20
0.38
0.00
6.52
0.46
5.20

95% CI

β

[5.86, 30.53]
[.29, .47]
[-.34, .34]
[-.53, 13.57]
[-6.63, 7.55]
[2.14, 8.25]

0.42
0.00
0.10
0.01
0.18

t

p

2.90
8.04
0.01
1.82
0.13
3.34

.004
.000
.995
.070
.899
.001

A multiple regression analysis was run to determine how time one neurocognitive
domain scores, duration of illness, gender, race, and stress predicted symptom scores for
the neurocognitive domain at time two (Table 8). Multiple R2 = 0.32, F(5, 280) = 26.08, p
= .000. This model demonstrated prediction of time two symptom scores for the
neurocognitive domain from time one scores, identifying as female, and stress, with an
increase in time two neurocognitive domain scores connected to an increase in time one
neurocognitive domain score, being female, and stress score. When time one
neurocognitive domain score is held constant, time two score b = 0.40 and p = .000.
When considering the female gender, time two neurocognitive domain score b = 7.78 and
p = .031, which indicates that females report a higher change in neurocognitive domain
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scores compared to males. When stress is held constant, time two neurocognitive domain
score b = 7.23 and p = .000. This indicates that time one neurocognitive domain scores,
the female gender, and stress scores account for a significant prediction of time two
neurocognitive domain scores, whereas duration of illness and race do not.
Table 8. Regression analysis summary for stress predicting neurocognitive domain score
at time two.
Predictors
(Constant)
T1Neurocog
Duration
Female
BIPOC
Stress

B
10.27
0.40
0.00
7.78
2.12
7.23

95% CI
[-1.51, 22.04]
[.31, .48]
[-.34, .34]
[.73, 14.83]
[-5.01, 9.26]
[4.18, 10.29]

β
0.44
0.00
0.11
0.03
0.24

t

p

1.72
8.77
0.02
2.17
0.59
4.66

.087
.000
.984
.031
.558
.000

A multiple regression analysis was run to determine how time one immune
domain scores, duration of illness, gender, race, and stress predicted symptom scores for
the immune domain at time two (Table 9). Multiple R2 = 0.30, F(5, 280) = 25.40, p =
.000. This model demonstrated prediction of time two symptom scores for the immune
domain from time one scores, with an increase in time two immune domain scores
connected to an increase in time one immune domain score. When time one immune
domain score is held constant, time two score b = 0.42 and p = .000. This indicates that
time one immune domain scores account for a significant prediction of time two immune
domain scores, whereas duration of illness, gender, race, and stress do not.
Table 9. Regression analysis summary for stress predicting immune domain score at time
two.
Predictors

B

(Constant)
T1Immune
Duration

1.43
0.42
-0.72

95% CI

β

[-6.27, 9.13]
[.34, .50]
[-.29, .14]

0.55
-0.33

t
0.33
10.72
-0.65

p
.715
.000
.517
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Female
BIPOC
Stress

-0.56
2.43
0.51

[-5.12, 3.99]
[-2.15, 7.02]
[-1.48, 2.50]

-0.12
0.05
0.03

-0.24
1.04
0.51

.809
.297
.614

A multiple regression analysis was run to determine how time one neuroendocrine
domain scores, duration of illness, gender, race, and stress predicted symptom scores for
the neuroendocrine domain at time two (Table 10). Multiple R2 = 0.36, F(5, 280) = 31.54,
p = .000. This model demonstrated prediction of time two symptom scores for the
neuroendocrine domain from time one scores and stress, with an increase in time two
neuroendocrine domain scores connected to an increase in time one neuroendocrine
domain score and stress scores. When time one neuroendocrine domain score is held
constant, time two score b = 0.47 and p = .000. When stress is held constant, time two
neuroendocrine domain score b = 2.25 and p = .043. This indicates that time one
neuroendocrine domain scores and stress scores account for a significant prediction of
time two neuroendocrine domain scores, whereas duration of illness, gender, and race do
not.
Table 10. Regression analysis summary for stress predicting neuroendocrine domain
score at time two.
Predictors
(Constant)
T1Neuroend
Duration
Female
BIPOC
Stress

B
1.98
0.47
-0.11
0.53
0.64
2.25

95% CI
[-6.29, 10.24]
[.39, .56]
[-.35, .13]
[-4.48, 5.54]
[-4.38, 5.65]
[.07, 4.43]

β
0.56
-0.04
0.01
0.01
0.10

t
0.47
11.30
-0.90
0.21
0.25
2.03

p
.638
.000
.370
.836
.803
.043

A multiple regression analysis was run to determine how time one pain domain
scores, duration of illness, gender, race, and stress predicted symptom scores for the pain
domain at time two (Table 11). Multiple R2 = 0.36, F(5, 280) = 31.06, p = .000. This
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model demonstrated prediction of time two symptom scores for the pain domain from
time one scores, gender, and stress scores, with an increase in time two pain domain
scores connected to an increase in time one pain domain score and stress score, along
with being female. When time one pain domain score is held constant, time two score b =
0.53 and p = .000. When the female gender is considered, time two pain domain score b =
8.55 and p = .026. When stress is held constant, time two pain domain score b = 4.29 and
p = .000. This indicates that time one pain domain scores, being female, and stress scores
account for a significant prediction of time two pain domain scores, whereas duration of
illness and race do not.
Table 11. Regression analysis summary for stress predicting pain domain score at time
two.
Predictors

B

(Constant)
T1Pain
Duration
Female
BIPOC
Stress

6.69
0.53
-0.13
8.55
-5.62
4.29

95% CI

β

[-6.10, 19.49]
[.44, .62]
[-.49, .23]
[1.04, 16.06]
[-13.24, 2.01]
[1.02, 7.56]

0.54
-0.03
0.11
-0.07
0.13

t
1.03
11.14
-0.71
2.24
-1.45
2.58

p
.304
.000
.479
.026
.148
.010

A multiple regression analysis was run to determine how time one gastrointestinal domain scores, duration of illness, gender, race, and stress predicted symptom
scores for the gastro-intestinal domain at time two (Table 12). Multiple R2 = 0.39, F(5,
280) = 35.63, p = .000. This model demonstrated prediction of time two symptom scores
for the gastro-intestinal domain from time one scores, with an increase in time two
gastro-intestinal domain scores connected to an increase in time one gastro-intestinal
domain score. When time one gastro-intestinal domain score is held constant, time two
score b = 0.50 and p = .000. This indicates that time one gastro-intestinal domain scores
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account for significant prediction of time two gastro-intestinal domain scores, whereas
duration of illness, gender, race, and stress do not.
Table 12. Regression analysis summary for stress predicting gastro-intestinal domain
score at time two.
Predictors

B

(Constant)
T1Gastro
Duration
Female
BIPOC
Stress

1.98
0.50
-0.07
5.64
3.71
2.48

95% CI
[-7.92, 11.87]
[.42, .59]
[-.36, .22]
[-.34, 11.62]
[-2.34, 9.75]
[-.14, 5.11]

β
0.58
-0.02
0.09
0.06
0.09

t
0.39
12.03
-0.45
1.86
1.21
1.87

p
.694
.000
.651
.064
.228
.063

A multiple regression analysis was run to determine how time one orthostatic
domain scores, duration of illness, gender, race, and stress predicted symptom scores for
the orthostatic domain at time two (Table 13). Multiple R2 = 0.36, F(5, 280) = 31.39, p =
.000. This model demonstrated prediction of time two symptom scores for the orthostatic
domain from time one scores and stress, with an increase in time two orthostatic domain
scores connected to an increase in time one orthostatic domain score and stress scores.
When time one orthostatic domain score is held constant, time two score b = 0.46 and p =
.000. When stress is held constant, time two orthostatic domain score b = 4.08 and p =
.001. This indicates that time one orthostatic domain scores and stress scores account for
a significant prediction of time two orthostatic domain scores, whereas duration of
illness, gender, and race do not.
Table 13. Regression analysis summary for stress predicting orthostatic domain score at
time two.
Predictors

B

(Constant)
T1Ortho
Duration

10.42
0.46
-0.20

95% CI

β

[1.22, 19.62]
[.37, .54]
[-.46, .06]

0.53
-0.07

t
2.23
10.87
-2.51

p
.027
.000
.133

30
Female
BIPOC
Stress

0.05
3.11
4.08

[-5.39, 5.49]
[-2.36, 8.48]
[1.72, 6.44]

0.00
0.05
0.17

0.02
1.12
3.40

.987
.265
.001

A multiple regression analysis was run to determine how time one CDC domain
scores, duration of illness, gender, race, and stress predicted symptom scores for the CDC
domain at time two (Table 14). Multiple R2 = 0.43, F(5, 280) = 32.85, p = .000. This
model demonstrated prediction of time two symptom scores for the CDC domain from
time one scores and stress scores, with an increase in time two CDC domain scores
connected to an increase in time one CDC domain score and stress scores. When time one
CDC domain score is held constant, time two score b = 0.55 and p = .000. When stress is
held constant, time two CDC domain score b = 2.15 and p = .021. This indicates that time
one CDC domain scores and stress scores account for a significant prediction of time two
CDC domain scores, whereas duration of illness, gender, and race do not.
Table 14. Regression analysis summary for stress predicting CDC domain score at time
two.
Predictors

B

(Constant)
T1CDC
Duration
Female
BIPOC
Stress

2.51
0.55
-0.19
1.65
-3.26
2.15

95% CI
[-4.40, 9.52]
[.47, .64]
[-.39, .01]
[-2.44, 5.74]
[-7.39, .86]
[.32, 3.98]

β
0.60
-0.09
0.04
-0.07
0.11

t
0.72
12.55
-1.92
0.79
-1.56
2.32

p
.475
.000
.056
.428
.120
.021

To assess the degree of variance that is accounted for by social support, gender,
and race on time point two symptom domain scores, these variables were entered into a
multiple regression analysis model. Time one domain scores were also entered into the
model as a predictor. In addition, to account for participant duration of illness, this
variable was entered into the model as well.
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A multiple regression analysis was run to determine how time one sleep domain
scores, duration of illness, gender, race, and social support predicted symptom scores for
the sleep domain at time two (Table 15). Multiple R2 = 0.31, F(5, 279) = 25.36, p = .000.
This model demonstrated prediction of time two symptom scores for the sleep domain
from time one scores and social support scores, with an increase in time two sleep
domain scores connected to an increase in time one sleep domain score and social support
scores. When time one sleep domain score is held constant, time two score b = 0.49 and p
= .000. When social support is held constant, time two sleep domain score b = 4.86 and p
< .001. This indicates that time one sleep domain scores and social support scores
account for a significant prediction of time two sleep domain scores, whereas duration of
illness, gender, and race do not.
Table 15. Regression analysis summary for social support predicting sleep domain score
at time two.
Predictors

B

(Constant)
T1Sleep
Duration
Female
BIPOC
Support

15.85
0.49
-0.11
-1.65
2.69
4.86

95% CI

β

[5.49, 26.21]
[.39, .59]
0.51
[-.41, .18]
-0.38
[-7.80, 4.50] -0.03
[-3.53, 8.91] 0.04
[2.06, 7.66]
0.17

t
3.01
10.01
-0.75
-0.53
0.85
3.41

p
.003
.000
.454
.598
.395
.001

A multiple regression analysis was run to determine how time one PEM domain
scores, duration of illness, gender, race, and social support predicted symptom scores for
the PEM domain at time two (Table 16). Multiple R2 = 0.24, F(5, 279) = 18.05, p = .000.
This model demonstrated prediction of time two symptom scores for the PEM domain
from time one scores only, with an increase in time two PEM domain scores connected to
an increase in time one PEM domain score. When time one PEM domain score is held
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constant, time two score b = 0.40 and p = .000. This indicates that time one PEM domain
scores account for a significant prediction of time two sleep domain scores, whereas
duration of illness, gender, race, and social support do not.
Table 16. Regression analysis summary for social support predicting PEM domain score
at time two.
Predictors

B

(Constant)
T1PEM
Duration
Female
BIPOC
Support

22.72
0.40
-0.05
6.91
1.14
3.06

95% CI
[10.54, 34.89]
[.30, .49]
[-.39, .29]
[-.25, 14.08]
[-6.09, 8.37]
[-.20, 6.32]

β
0.44
-0.02
-0.10
0.02
0.10

t
3.67
8.35
-0.28
1.90
0.31
1.85

p
.000
.000
.780
.059
.756
.065

A multiple regression analysis was run to determine how time one neurocognitive
domain scores, duration of illness, gender, race, and social support predicted symptom
scores for the neurocognitive domain at time two (Table 17). Multiple R2 = 0.28, F(5,
279) = 22.03, p = .000. This model demonstrated prediction of time two symptom scores
for the neurocognitive domain from time one scores, identifying as female, and social
support scores, with an increase in time two neurocognitive domain scores connected to
an increase in time one neurocognitive domain and social support scores, along with
being female. When time one neurocognitive domain score is held constant, time two
score b = 0.40 and p = .000. When the female gender is considered, time two
neurocognitive domain score b = 8.51 and p = .021. When social support is held constant,
time two neurocognitive domain score b = 4.91 and p = .004. This indicates that time one
neurocognitive domain scores, being female, and social support scores account for a
significant prediction of time two neurocognitive domain scores, whereas duration of
illness and race do not.
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Table 17. Regression analysis summary for social support predicting neurocognitive
domain score at time two.
Predictors
(Constant)
T1Neurocog
Duration
Female
BIPOC
Support

B
16.82
0.40
-0.07
8.51
3.03
4.91

95% CI
[5.32, 28.32]
[.31, .49]
[-.41, .28]
[1.30, 15.71]
[-4.30, 10.36]
[1.61, 8.21]

β
0.45
-0.02
0.12
0.04
0.15

t
2.88
8.71
-0.38
2.32
0.81
2.93

p
.004
.000
.706
.021
.417
.004

A multiple regression analysis was run to determine how time one immune
domain scores, duration of illness, gender, race, and social support predicted symptom
scores for the immune domain at time two (Table 18). Multiple R2 = 0.32, F(5, 279) =
26.30, p = .000. This model demonstrated prediction of time two symptom scores for the
immune domain from time one scores and social support, with an increase in time two
immune domain scores connected to an increase in time one immune domain score and
social support scores. When time one immune domain score is held constant, time two
score b = 0.41 and p = .000. When social support is held constant, time two immune
domain score b = 2.13 and p = .045. This indicates that time one immune domain scores
and social support scores account for a significant prediction of time two immune domain
scores, whereas duration of illness, gender, and race do not.
Table 18. Regression analysis summary for social support predicting immune domain
score at time two.
Predictors

B

(Constant)
T1Immune
Duration
Female
BIPOC
Support

-0.21
0.41
-0.08
-0.88
2.93
2.13

95% CI
[-7.57, 7.16]
[.34, .49]
[-.30, .14]
[-5.42, 3.66]
[-1.66, 7.52]
[.05, 4.22]

β
0.53
-0.04
-0.02
0.06
0.10

t
-0.06
10.53
-0.74
-0.38
1.26
2.01

p
.956
.000
.463
.702
.211
.045
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A multiple regression analysis was run to determine how time one neuroendocrine
domain scores, duration of illness, gender, race, and social support predicted symptom
scores for the neuroendocrine domain at time two (Table 19). Multiple R2 = 0.35, F(5,
279) = 30.41, p = .000. This model demonstrated prediction of time two symptom scores
for the neuroendocrine domain from time one scores only, with an increase in time two
neuroendocrine domain scores connected to an increase in time one neuroendocrine
domain score. When time one neuroendocrine domain score is held constant, time two
score b = 0.48 and p = .000. This indicates that time one neuroendocrine domain scores
account for a significant prediction of time two neuroendocrine domain scores, whereas
duration of illness, gender, race, and social support do not.
Table 19. Regression analysis summary for social support predicting neuroendocrine
domain score at time two.
Predictors
(Constant)
T1Neuroend
Duration
Female
BIPOC
Support

B
4.44
0.48
-0.13
0.74
0.84
1.05

95% CI
[-3.55, 12.42]
[.40, .57]
[-.37, .11]
[-4.32, 5.79]
[-4.24, 5.92]
[-1.26, 3.37]

β
0.58
-0.05
0.01
0.02
0.04

t
1.09
11.55
-1.07
0.29
0.33
0.90

p
.275
.000
.288
.774
.745
.371

A multiple regression analysis was run to determine how time one pain domain
scores, duration of illness, gender, race, and social support predicted symptom scores for
the pain domain at time two (Table 20). Multiple R2 = 0.36, F(5, 279) = 30.97, p = .000.
This model demonstrated prediction of time two symptom scores for the pain domain
from time one scores, identifying as female, and social support scores, with an increase in
time two pain domain scores connected to an increase in time one pain domain and social
support scores, along with being female. When time one pain domain score is held
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constant, time two score b = 0.53 and p = .000. When the female gender is considered,
time two pain domain score b = 8.57 and p = .026. When social support is held constant,
time two pain domain score b = 4.58 and p = .010. This indicates that time one pain
domain scores, identifying as female, and social support scores account for a significant
prediction of time two pain domain scores, whereas duration of illness and race do not.
Table 20. Regression analysis summary for social support predicting pain domain score
at time two.
Predictors

B

(Constant)
T1Pain
Duration
Female
BIPOC
Support

8.53
0.53
-0.18
8.57
-4.63
4.58

95% CI
[-3.73, 20.80]
[.43, .62]
[-.54, .19]
[1.05, 16.10]
[-12.32, 3.05]
[1.11, 8.06]

β
0.54
-0.05
0.11
-0.06
0.13

t
1.37
11.07
-0.96
2.24
-1.19
2.60

p
.172
.000
.338
.026
.236
.010

A multiple regression analysis was run to determine how time one gastrointestinal domain scores, duration of illness, gender, race, and social support predicted
symptom scores for the gastro-intestinal domain at time two (Table 21). Multiple R2 =
0.39, F(5, 279) = 35.80, p = .000. This model demonstrated prediction of time two
symptom scores for the gastro-intestinal domain from time one scores only, with an
increase in time two gastro-intestinal domain scores connected to an increase in time one
gastro-intestinal domain score. When time one gastro-intestinal domain score is held
constant, time two score b = 0.51 and p = .000. This indicates that time one gastrointestinal domain scores account for a significant prediction of time two gastro-intestinal
domain scores, whereas duration of illness, gender, race, and social support do not.
Table 21. Regression analysis summary for social support predicting gastro-intestinal
domain score at time two.
Predictors

B

95% CI

β

t

p
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(Constant)
T1Gastro
Duration
Female
BIPOC
Support

2.73
0.51
-0.90
5.66
4.22
2.67

[-6.73, 12.19]
[.43, .59]
[-.38, .20]
[-.32, 11.63]
[-1.86, 10.29]
[-.10, 5.43]

0.58
-0.03
0.09
0.07
0.09

0.57
12.15
-0.62
0.09
0.07
0.09

.570
.000
.539
.064
.173
.059

A multiple regression analysis was run to determine how time one orthostatic
domain scores, duration of illness, gender, race, and social support predicted symptom
scores for the orthostatic domain at time two (Table 22). Multiple R2 = 0.35, F(5, 279) =
31.45, p = .000. This model demonstrated prediction of time two symptom scores for the
orthostatic domain from time one scores and social support scores, with an increase in
time two orthostatic domain scores connected to an increase in time one orthostatic
domain score and social support scores. When time one orthostatic domain score is held
constant, time two score b = 0.46 and p = .000. When social support is held constant,
time two orthostatic domain score b = 4.37 and p = .001. This indicates that time one
orthostatic domain scores and social support scores account for a significant prediction of
time two orthostatic domain scores, whereas duration of illness, gender, and race do not.
Table 22. Regression analysis summary for social support predicting orthostatic domain
score at time two.
Predictors

B

(Constant)
T1Ortho
Duration
Female
BIPOC
Support

11.99
0.46
-0.25
-0.05
4.10
4.37

95% CI

β

[3.16, 20.83]
[.38, .54]
0.54
[-.51, .02]
-0.09
[-5.50, 5.40] 0.00
[-1.41, 9.60] 0.07
[1.87, 6.87]
0.17

t
2.67
10.88
-1.86
-0.02
1.47
3.44

p
.008
.000
.064
.985
.144
.001

A multiple regression analysis was run to determine how time one CDC domain
scores, duration of illness, gender, race, and social support predicted symptom scores for
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the CDC domain at time two (Table 23). Multiple R2 = 0.43, F(5, 279) = 42.12, p = .000.
This model demonstrated prediction of time two symptom scores for the CDC domain
from time one scores and duration of illness, with an increase in time two CDC domain
scores connected to an increase in time one CDC domain score and a decrease in scores
related to duration of illness. When time one CDC domain score is held constant, time
two score b = 0.57 and p = .000. When duration of illness is held constant, time two CDC
score b = -0.21 and p < .033. This indicates that time one CDC domain scores and
duration of illness account for a significant prediction of time two CDC domain scores,
whereas gender, race, and social support do not.
Table 23. Regression analysis summary for social support predicting CDC domain score
at time two.
Predictors

B

(Constant)
T1CDC
Duration
Female
BIPOC
Support

4.07
0.57
-0.21
1.63
-2.94
1.36

95% CI

β

[-2.67, 10.82]
[.49, .66]
[-.41, -.02]
[-2.49, 5.74]
[-7.10, 1.23]
[-.53, 3.25]

0.62
-0.10
0.04
-0.06
0.07

t
1.19
13.31
-2.15
0.78
-1.39
1.42

p
.236
.000
.033
.437
.166
.157

Discussion
Although the COVID-19 pandemic has had an impact on nearly every person
around the world, not everyone has been impacted equally. Understanding the nuances in
the experiences of different groups of people allows for a more in-depth analysis of the
effects of the pandemic, which will be necessary for repairing the damage left behind.
One group that has been uniquely affected by the coronavirus disease is COVID-19 longhaulers, a group that has been struggling with lasting symptoms of the virus (CDC, 2020;
WHO, 2020). Because the course of chronic illness can be impacted by an individual’s

38
experience of stress and social support, garnering a deeper understanding of how these
psychosocial factors affect COVID-19 long-haulers specifically is critical to this group’s
recovery process, which this study sought to do. In addition, understanding who is
potentially more vulnerable along certain demographic characteristics within this specific
population is also valuable for conceptualizing targeted treatment and intervention plans.
Overall, this study aimed to achieve a better understanding of which factors may be
associated with an increased vulnerability to long-term effects of COVID-19, which can
be used to direct resources to these individuals, give credence to their experiences, and
inform the effects future viruses may have on these populations.
One finding of this study supports previous research concerning the differences
between females and males in the course of their chronic illness. Results from this study
supported the hypothesis that females and males report different levels of symptom
severity and frequency related to their COVID-19 long-haul illness. Specifically, females
reported experiencing significantly higher symptom severity and frequency in several
symptom domains at both time points, compared to males. These symptoms domains
include those related to sleep, fatigue, immunological concerns, pain, gastro-intestinal
concerns, and orthostatic concerns. Overall, females reported experiencing higher
symptom severity and frequency in various areas of the body, which demonstrates the
multi-system nature of the COVID-19 long-haul illness. This is especially significant for
this long-hauler population, as these symptoms endure for extended periods of time and
can therefore disrupt several areas of a person’s life.
Related to the demonstrated basic differences between females and males, this
study also supported the hypothesis that being female is a predictor of increased COVID-
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19 symptom severity and frequency. This finding is significant given the psychosocial
theory, which indicates that women have different experiences related to their
environments, which is associated with experiencing different levels of stress and social
support. Given how the pandemic has affected women and men differently, the results of
this study are comprehensible. Specifically, females in this study were more likely to
report increased symptom frequency and severity for the neurocognitive and pain
domains from time one to time two, compared to males. This is significant as these
groups of symptoms have been reported frequently by female COVID-19 long-haulers
anecdotally (O’Rourke, 2021; Rubin, 2020; Velasquez-Manoff, 2021).
These gender findings are supported by previous chronic illness research, which
has also found that identifying as female is associated with an increased likelihood of
experiencing long-term post-viral effects as compared to males, especially symptoms
related to pain (Curtis et al., 2010; Wagner & Jason, 1997; Zautra et al., 1999). These
findings have implications for treatment and intervention plans, which must consider the
unique physical and psychological experiences of women. In addition, these findings
offer support to the female COVID-19 long-haulers who experienced increased stress and
decreased social support as a result of the pandemic, as well as to those who may feel as
though their illness has gone unbelieved and has thus been a source of stigma.
Although gender differences were found in this study, race differences were not.
Results from this study do not support the hypothesis that participants who identify as
White differ in reported symptom severity and frequency compared to BIPOC
participants. More specifically, BIPOC participants did not report significantly increased
symptom severity and frequency compared to White participants. In addition, identifying
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as a BIPOC participant did not predict increased COVID-19 symptomatology severity
and frequency at time two in any of the nine symptom domains. These findings do not
support the psychosocial theory, which predicts that the impacts of stress related to racial
discrimination negatively affect chronic illness outcomes (Cohen, 1988; Duru, 2012;
Gilbert-Ouimet, 2014; Nobles et al., 2015). For this sample of long-haulers, race was not
a significant contributing factor to COVID-19 illness severity and frequency.
In addition to gender and race, stress and social support have been shown to be
associated with the course of chronic illness (Devendorf et al., 2016; Earnshaw et al.,
2011; Gallant, 2003; Hatcher et al., 2003). Results from this study support the hypothesis
that both stress and social support are significant predictors of several COVID-19
symptom domains. Particularly, the prediction of stress indicates that, for those reporting
increased stress related to the pandemic, there is an increased likelihood in reporting
symptoms related to sleep issues, fatigue, cognition difficulties, endocrine concerns, pain,
orthostatic concerns, and increased experiences of the hallmark symptoms of COVID-19
reported by the CDC. These findings indicate that stress is associated with the overall
decreased physical and psychological functioning of COVID-19 long-haulers.
In addition to stress, the prediction of social support indicates that those reporting
decreased social support as a result of the pandemic have been more likely to report
increased symptom severity and frequency related to sleep, cognition, immune, pain, and
orthostatic concerns. These findings signify that those who have reported being better
able to rely on their strong systems of social support have also reported less frequent and
severe COVID-19 symptomatology, indicating that they have been better able to cope
with their COVID-19 long-haul illness and its symptoms. Overall, these findings align
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with the psychosocial theory, which states that increased experiences of stress and
decreased social support can be significantly related to the course of chronic illness.
Improving these psychological factors for COVID-19 long-haulers will be critical to
comprehensive treatment and intervention plans.
Limitations
Overall, there were several factors that may have limited the results of this study.
Due to convenience sampling, the sample for this study was composed primarily of
White, highly educated, high-income women. Although obtaining the perspective of
women is critical, especially because of the specific impacts they have faced as a result of
the pandemic (CDC, 2020; O’Rourke, 2021; Robertson & Gebeloff, 2020), educated and
wealthy women will have had different experiences related to the pandemic than women
who face racial discrimination, for example, or those who are less educated and
financially stable. More educated women long-haulers, for example, may have had less
stress related to their illness and the pandemic generally because they may have been
more likely to be able to work from home or take time off from work altogether.
In addition to the bias in gender sampling, this study did not capture an in-depth
view of the differences within the BIPOC group. It is clear that the BIPOC population is
not one homogenous group and the analyses for this study failed to capture those
differences. By placing all Black/African American participants with all Asian/Pacific
Islander participants, for example, the contextual differences brought about by society are
overlooked. Both of these groups have experienced increased stress during the pandemic;
however, their stress has manifested in different forms. In addition, not all participants
were from the United States, which may also account for varying experiences. For future
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studies, capturing the experiences of diverse populations is critical. One way this can be
done is through targeted recruitment. Because this study was conducted during
lockdowns and quarantines as an online survey primarily through social media, it was
difficult to specifically recruit long-haulers of diverse backgrounds.
One general concern of the survey is that related to recall effects. Participants
were asked to recall their symptoms not only within the last two weeks, but all the way
back to their first two weeks of illness, which for some participants was several months in
the past. Although time point one was controlled for in regression analyses, recall effects
still impact participant response. For example, participants who remember their course of
illness as progressively worsening may have under-reported symptom severity and
frequency in the first two weeks of illness. This issue of recall is especially problematic
for the COVID-19 long-hauler population, as commonly reported symptoms are
neurocognitive issues related to memory, which were demonstrated in this study,
particularly for female participants.
A statistical limitation of this study is the high skew of the illness domain at time
point two. The high skew of this domain showed that participants rated these symptoms
as not severe and not frequent, which indicates that the symptoms (e.g., high fever; sore
throat) were not of major concern for this group during the past two weeks of their
illness. This domain was not transformed in order to retain interpretability in relation to
the other symptom domains. However, not transforming this domain remained a problem
for the t-test and regression model, as normality for this domain could not be assumed
and thus imposed limitations on the results.
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Future Directions
Further comprehension of the long-term effects of COVID-19 on the long-hauler
population will be crucial for future research. Although the pandemic is nearing an end
with increased vaccination, long-haulers may endure the effects of the coronavirus for
years to come. Finding new ways to reach vulnerable groups (e.g., BIPOC, those without
health insurance, people of low socioeconomic status) will be especially important as
treatment programs emerge for the more privileged in our society (O’Rourke, 2021;
Velasquez-Manoff, 2021). Another factor that will provide insight is understanding how
the online support groups of COVID-19 long-haulers have benefited as well as
potentially hurt (e.g., through the spread of misinformation) this population throughout
the pandemic and how this platform can be expanded to more holistically support those
with chronic illness.
Overall, this study has demonstrated that COVID-19 long-haulers are afflicted
with a wide variety of symptoms. In addition, this study showed that stress and social
support are associated with a wide variety of symptoms experienced by this group. Along
with stress and social support, gender differences have also been found, demonstrating
that women and men report different levels of psychological and physical symptoms
caused by COVID-19, which has also been demonstrated in the course of past viral
infections (Buchwald et al., 2000; Radusin, 2012; Wilson et al., 2019). In order to move
forward, further exploration of the long-term course of illness within this group needs to
be evaluated, especially for racial and ethnic minorities in America. In addition,
discovering how to increase social support and decrease stress within the COVID-19
long-hauler population may also be critical in their treatment and recovery, for both
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physical and psychological reasons. In addition, understanding the long-term effects of
COVID-19 may also be critical for increasing awareness of other long-term chronic
illnesses, such as ME/CFS. Although the most pressing concerns related to the pandemic
will likely start to abate as more people receive COVID-19 vaccinations, the long-term
psychosocial, economic, and cultural consequences of the pandemic are unclear,
especially for COVID-19 long-haulers.
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Appendix A: DePaul Symptom Questionnaire Symptoms by Domain
Domain

Symptoms (measured on frequency and severity)

Sleep

● Feeling unrefreshed after you wake up in the
morning
● Need to nap daily
● Problems falling asleep
● Problems staying asleep
● Waking up early in the morning (e.g. 3am)

Post-exertional malaise
(PEM)

● Dead, heavy feeling after starting to exercise
● Next day soreness or fatigue after non-strenuous,
everyday activities
● Mentally tired after the slightest effort
● Minimum exercise makes you physically tired
● Physically drained or sick after mild activity
● Muscle weakness

Neurocognitive
(Neurocog)

● Problems remembering things
● Difficulty paying attention for a long period of
time
● Difficulty finding the right word to say or
expressing thoughts
● Difficulty understanding things
● Only able to focus on one thing at a time
● Slowness of thought
● Absent-mindedness or forgetfulness

Immune

●
●
●
●

Sore throat
Tender / Sore lymph nodes
Fever
Flu-like symptoms

Neuroendocrine
(Neuroend)

●
●
●
●

Cold limbs (e.g. arms, legs, hands)
Feeling chills or shivers
Feeling hot or cold for no reason
Feeling like you had a low temperature

Pain

● Pain or aching in your muscles
● Pain / stiffness / tenderness in more than one joint
without swelling or redness

Gastro-intestinal
(Gastro)

● Bloating
● Abdomen / Stomach pain
● Irritable bowel problems
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Orthostatic
(Ortho)

● Chest pain
● Feeling unsteady on your feet, like you might fall
● Shortness of breath or trouble catching your
breath
● Dizziness or fainting
● Irregular heart beats

CDC

●
●
●
●
●
●

Dry cough
Loss of taste and smell
Difficulty breathing
Diarrhea
Congestion or runny nose
Hair loss

